Our understanding of the clinical presentation, natural history, and responses to therapy of OPGs, both ONGs and OCGs, is steadily increasing. At the same time, the molecular biology and genetics of these tumors are becoming increasingly clear in both NF1 and non-NF1 patients. It is to be hoped that an understanding of these issues hopefully will lead to molecular therapies (?gene therapy, ?nanoparticles) to prevent or treat these lesions.
ASJC Scopus subject areas
- Clinical Neurology